THE RECENT TRIALS FOR ASPIRIN IN THE PREVENTION OF CARDIOVASCULAR MORTALITY

被引：3
|
作者：
CHESEBRO, JH
OPIE, LH
FUSTER, V
机构：
来源：
CARDIOVASCULAR DRUGS AND THERAPY | 1989年 / 3卷 / 03期
关键词：
D O I：
10.1007/BF01858107
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：353 / 354
页数：2
相关论文
共 50 条
  • [31] Optimizing the Use of Aspirin for Cardiovascular Prevention
    Casado-Arroyo, Ruben
    Sostres, Carlos
    Lanas, Angel
    DRUGS, 2013, 73 (08) : 803 - 814
  • [32] Optimizing the Use of Aspirin for Cardiovascular Prevention
    Rubén Casado-Arroyo
    Carlos Sostres
    Angel Lanas
    Drugs, 2013, 73 : 803 - 814
  • [33] Aspirin in the Prevention of Cardiovascular Disease and Cancer
    Ricciotti, Emanuela
    FitzGerald, Garret A.
    ANNUAL REVIEW OF MEDICINE, VOL 72, 2021, 2021, 72 : 473 - 495
  • [34] Aspirin for primary prevention of cardiovascular disease
    Capodanno, Davide
    Angiolillo, Dominick J.
    LANCET, 2018, 392 (10152): : 988 - 990
  • [35] Aspirin for Prevention and Treatment of Cardiovascular Disease
    Mehta, Shamir R.
    ANNALS OF INTERNAL MEDICINE, 2009, 150 (06) : 414 - 416
  • [36] Aspirin for primary prevention of cardiovascular disease
    Waltering, A
    Hemkens, L
    Florack, C
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (49) : 2847 - 2852
  • [37] Aspirin in the treatment and prevention of cardiovascular disease
    Hennekens, CH
    ANNUAL REVIEW OF PUBLIC HEALTH, 1997, 18 : 37 - 49
  • [38] Aspirin in the treatment and prevention of cardiovascular disease
    Gaziano, JM
    Skerrett, PJ
    Buring, JE
    HAEMOSTASIS, 2000, 30 : 1 - 13
  • [39] Aspirin for the primary prevention of cardiovascular diseases
    Ludovica Tagliabue
    Franca Dipaola
    Francesca Perego
    Gian Marco Podda
    Internal and Emergency Medicine, 2012, 7 : 375 - 379
  • [40] Aspirin as a "gold standard" in cardiovascular prevention
    Nedogoda, S., V
    RUSSIAN JOURNAL OF CARDIOLOGY, 2010, (03): : 86 - 89
12345